Why Kindred Biosciences Stock Skyrocketed Today

Why Kindred Biosciences Stock Skyrocketed Today

Shares of Kindred Biosciences (NASDAQ: KIN) soared 46% on Wednesday after the pet-focused biotech company said it agreed to be acquired by Elanco Animal Health (NYSE: ELAN). KindredBio will help to bolster Elanco's pet therapeutic pipeline in fast-growing markets such as dermatology. The combination is also projected to strengthen Elanco's relationships with veterinary clinics.